Global Patient Safety – Specialty TA Intern

Job Description

Global Patient Safety, Specialty TA Intern Overview  

Envision spending your summer working with energetic colleagues and inspirational leaders, all while gaining world-class experience in one of the most dynamic organizations in the pharmaceutical industry. This is a reality for AbbVie Interns. 

Global Patient Safety, Specialty TA Intern Overview  

Envision spending your summer working with energetic colleagues and inspirational leaders, all while gaining world-class experience in one of the most dynamic organizations in the pharmaceutical industry. This is a reality for AbbVie Interns. 

As a Global Patient Safety, Specialty Therapeutic Area (TA) Intern at AbbVie, you will spend your summer engaged with energetic colleagues and inspirational leaders, gaining world-class experience within one of the most dynamic organizations in the pharmaceutical industry. You will support the Obesity products under the Specialty Therapeutic Area in the Global Patient Safety (GPS) organization. You will learn GPS processes and deliverables relevant to clinical development and patient safety. 

The Global Patient Safety (GPS) organization works collaboratively and strategically with colleagues across the product lifecycle to identify, evaluate, understand, and communicate the safety profile of AbbVie products to protect patients worldwide. The team plays a critical role in evaluating safety data relevant to AbbVie for both pharmaceutical and medical device products.  

The team is a high-profile and high-impact group of physicians and other health care professionals who work in close collaboration with a broad range of cross-functional colleagues. The team works collaboratively to provide product data analysis, signal monitoring and product insights so that together as a team, the Product Safety Team (PST) can implement appropriate actions to ensure patient safety. 

As a member of the team, you are at the forefront of working with leaders to identify critical priorities and drive high-value projects that make an impact on the safety of our patients. 

Key Responsibilities Include: 

• Collaborate with the TA Head, Group Medical Director, and PST Lead to identify questions, gaps, and opportunities where Artificial Intelligence (AI) and other technology solutions can support the Obesity Asset Strategy Team; 

• Analyze existing clinical and real-world data sources and modelling platforms to refine patient population definitions, assess competitor products, and identify gaps in current obesity treatment and utilization;  

• Evaluate and summarize safety profiles of approved and investigational obesity products using publicly available safety data to inform strategy and development decisions;  

• Work across the Clinical Sciences organization (e.g., Epidemiology, Statistical Sciences, Clinical Pharmacology, and GPS) to discover, evaluate, and align on areas of opportunity for leveraging AI tools and databases, liaising with Obesity team members and leadership to reduce redundancies and streamline data, analytics, and tool use; 

• Learn and apply GPS processes relevant to clinical development, patient safety, and Obesity franchise deliverables; and 

• Contribute to key expedited GPS deliverables for the Obesity team. 

Qualifications

Minimum Qualifications  

• Currently enrolled in university, pursuing a PharmD or PhD in pharmacology, life sciences, healthcare, or other related degree. 

• Must be enrolled in university for at least one semester following the internship.

• Ability to leverage AI and technology solutions to complete safety profile evaluations.

• Experience working with real-world data sources and modelling platforms to refine patient population definitions, assess competitor products, and identify gaps in current obesity treatment and utilization. 

• Ability to summarize complex information.

• Strong verbal and written communication skills.

• Takes initiative and always looks for improvement opportunities.

Preferred Qualifications 

• Expected graduation date between December 2026 – June 2027. 

Benefits and Amenities  

• Competitive pay.  

• Relocation support for eligible students. 

• Opportunities for professional development and mentorship. 

• Access to dynamic project experiences within a world-class pharmaceutical organization.